Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis

Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH)

(2012) M. Hjelkrem et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

(2012) Carmela Loguercio et al.   FREE RADICAL BIOLOGY AND MEDICINE

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

(2012) Kenneth Cusi   GASTROENTEROLOGY

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adipokines and Redox Signaling: Impact on Fatty Liver Disease

(2011) Maurizio Parola et al.   ANTIOXIDANTS & REDOX SIGNALING

Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: A favorable endogenous response

(2011) Ramesh Kumar et al.   CLINICAL BIOCHEMISTRY

Biliverdin protects against the deterioration of glucose tolerance in db/db mice

(2011) N. Ikeda et al.   DIABETOLOGIA

Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis

(2011) Federico Salamone et al.   DIGESTIVE AND LIVER DISEASE

Non-alcoholic fatty liver disease: what's new under the microscope?

(2011) E. M. Brunt   GUT

The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice

(2011) Yong-Han Paik et al.   HEPATOLOGY

Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

(2010) Roberto Gambino et al.   ANTIOXIDANTS & REDOX SIGNALING

Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease

(2010) J.-P. Lin et al.   CLINICAL CHEMISTRY

Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis

(2010) Samuele De Minicis et al.   HEPATOLOGY

Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase

(2010) Masakazu Fujii et al.   KIDNEY INTERNATIONAL

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules

(2009) Graciela Luján Mazzone et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Histopathology of Non-Alcoholic Fatty Liver Disease

(2009) Elizabeth M. Brunt   Clinics in Liver Disease

Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice

(2009) Jun Yu et al.   GASTROENTEROLOGY

Curcumin limits the fibrogenic evolution of experimental steatohepatitis

(2009) Francesco Vizzutti et al.   LABORATORY INVESTIGATION

Bilirubin and glutathione have complementary antioxidant and cytoprotective roles

(2009) T. W. Sedlak et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury

(2008) G Serviddio et al.   GUT

Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome

(2008) Zeki Yesilova et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes

(2008) Michiaki Fukui et al.   KIDNEY INTERNATIONAL